Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

There is increased risk of developing hypertension in patients with self-reported snoring and excessive daytime sleepiness.